Maryam Rahman1, Dan Neal, Kyle M Fargen, Brian L Hoh. 1. Corresponding Author: Maryam Rahman, MD, MS, Department of Neurosurgery, University of Florida, PO Box 100265, Gainesville, FL 32610. mrahman@ufl.edu.
Abstract
BACKGROUND: The Agency for Healthcare Research and Quality (AHRQ) patient safety indicators (PSIs) and the Centers for Medicare and Medicaid Services (CMS) hospital acquired conditions (HACs) are used to evaluate the safety and quality of health care. We determined the incidence rates of PSIs and HACs among brain tumor patients in the Nationwide Inpatient Sample database (NIS). METHODS: We queried the NIS for all hospitalizations involving a brain tumor. We determined the incidence rates of various PSIs and HACs among these patients by searching the hospital records for codes in the International Classification of Diseases, 9th Revision indicating each PSI or HAC. RESULTS: Among the 501 908 hospitalizations involving a brain tumor in the NIS, there were 102 046 occurrences of an AHRQ PSI, with 16% of patients experiencing one or more AHRQ PSI. Among brain tumor patients treated without surgery, 17.2% experienced ≥ 1 PSI. Among brain tumor patients treated with surgery, 9.8% experienced ≥ 1 PSI. The most common PSIs were postoperative respiratory failure, deep vein thrombosis, and sepsis. The total number of HACs associated with brain tumor patients was 13 778, with 2.63% of patients experiencing ≥1 HAC. Among brain tumor patients treated without surgery, 3.0% experienced ≥ 1 HAC. Among brain tumor patients treated with surgery, 7.4% experienced ≥ 1 HAC. The most common HACs were falls and trauma and pressure ulcers. Increasing comorbidity score was associated with increased likelihood of almost all PSIs and HACs. CONCLUSION: These data may be used to determine individual institutional improvements or success by comparison.
BACKGROUND: The Agency for Healthcare Research and Quality (AHRQ) patient safety indicators (PSIs) and the Centers for Medicare and Medicaid Services (CMS) hospital acquired conditions (HACs) are used to evaluate the safety and quality of health care. We determined the incidence rates of PSIs and HACs among brain tumorpatients in the Nationwide Inpatient Sample database (NIS). METHODS: We queried the NIS for all hospitalizations involving a brain tumor. We determined the incidence rates of various PSIs and HACs among these patients by searching the hospital records for codes in the International Classification of Diseases, 9th Revision indicating each PSI or HAC. RESULTS: Among the 501 908 hospitalizations involving a brain tumor in the NIS, there were 102 046 occurrences of an AHRQ PSI, with 16% of patients experiencing one or more AHRQ PSI. Among brain tumorpatients treated without surgery, 17.2% experienced ≥ 1 PSI. Among brain tumorpatients treated with surgery, 9.8% experienced ≥ 1 PSI. The most common PSIs were postoperative respiratory failure, deep vein thrombosis, and sepsis. The total number of HACs associated with brain tumorpatients was 13 778, with 2.63% of patients experiencing ≥1 HAC. Among brain tumorpatients treated without surgery, 3.0% experienced ≥ 1 HAC. Among brain tumorpatients treated with surgery, 7.4% experienced ≥ 1 HAC. The most common HACs were falls and trauma and pressure ulcers. Increasing comorbidity score was associated with increased likelihood of almost all PSIs and HACs. CONCLUSION: These data may be used to determine individual institutional improvements or success by comparison.
Authors: Christopher P Landrigan; Gareth J Parry; Catherine B Bones; Andrew D Hackbarth; Donald A Goldmann; Paul J Sharek Journal: N Engl J Med Date: 2010-11-25 Impact factor: 91.245
Authors: Natalie B V Riblet; Evelyn M Schlosser; Karen Homa; Jennifer A Snide; Lesley A Jarvis; Nathan E Simmons; David H Sargent; Linda P Mason; Tobi J Cooney; Nancy L Kennedy; Camilo E Fadul Journal: J Oncol Pract Date: 2014-10-07 Impact factor: 3.840
Authors: Justin T Jordan; Amy E Sanders; Terri Armstrong; Tony Asher; Amy Bennett; Erin Dunbar; Nimish Mohile; P Leia Nghiemphu; Timothy R Smith; Douglas E Ney Journal: Neuro Oncol Date: 2018-03-27 Impact factor: 12.300
Authors: Christiane Menke; Sebastian Lohmann; Andrea Baehr; Oliver Grauer; Markus Holling; Benjamin Brokinkel; Michael Schwake; Walter Stummer; Stephanie Schipmann Journal: Neurooncol Pract Date: 2021-10-11
Authors: Natalie B V Riblet; Evelyn M Schlosser; Jennifer A Snide; Lara Ronan; Katherine Thorley; Melissa Davis; Jennifer Hong; Linda P Mason; Tobi J Cooney; Lanelle Jalowiec; Nancy L Kennedy; Sabrina Richie; David Nalepinski; Camilo E Fadul Journal: Neurooncol Pract Date: 2015-10-23